The main alkaloid found in the plant is mitragynine, which the body can metabolize into 7-hydroxymitragynine. When 7-hydroxymitragynine is extracted, concentrated, and pressed into tablets, the result is a substance with much stronger opioid-like activity than kratom 7 ohmz leaf powder itself.
Common Uses of 7-Hydroxymitragynine Tablets
People who seek out 7-hydroxymitragynine tablets often do so for several reasons:
1. Pain Relief – The compound is reported to provide strong analgesic effects, making it attractive to individuals dealing with chronic pain conditions.
2. Relaxation and Sedation – Because it can induce calmness, some use it to help with stress, anxiety, or insomnia.
3. Euphoria or Mood Enhancement – At higher doses, it may produce feelings of well-being or mild euphoria, which is one reason it has recreational appeal.
4. Opioid Withdrawal Aid – Some individuals use kratom and its alkaloids to manage withdrawal symptoms when tapering off prescription opioids or illicit opioids.
It’s important to note that while some people report benefits, scientific research is still limited, and there is no established medical approval for 7-hydroxymitragynine tablets.
Potential Risks and Side Effects
Because 7-hydroxymitragynine is much more potent than mitragynine, the risks are also higher. Potential side effects include:
Nausea, vomiting, or constipation
Drowsiness and dizziness
Itching or sweating
Loss of appetite
Dependence and withdrawal symptoms with frequent use
The most significant risk is that 7-hydroxymitragynine binds strongly to opioid receptors, which means it carries the potential for abuse and addiction. Unlike kratom leaf powder, which has a mixed stimulant-sedative profile, concentrated 7-hydroxymitragynine behaves more like a traditional opioid.
There have also been concerns about its role in kratom-related toxicity. Some laboratory studies suggest that 7-hydroxymitragynine is the main alkaloid responsible for the strongest opioid effects, raising red flags about safety when it is sold in pure or tablet form.
The compound itself is not scheduled at the federal level, but the U.S. Food and Drug Administration (FDA) has issued warnings about kratom and its alkaloids. Several states and cities have banned kratom or kratom-derived products.
Europe: Some European countries restrict or ban kratom and its alkaloids outright, while others have no specific laws.